198 related articles for article (PubMed ID: 27109380)
1. Quercetin targets the interaction of calcineurin with LxVP-type motifs in immunosuppression.
Zhao Y; Zhang J; Shi X; Li J; Wang R; Song R; Wei Q; Cai H; Luo J
Biochimie; 2016 Aug; 127():50-8. PubMed ID: 27109380
[TBL] [Abstract][Full Text] [Related]
2. A novel peptide exerts potent immunosuppression by blocking the two-site interaction of NFAT with calcineurin.
Wang L; Cheng N; Wang P; Li J; Jia A; Li W; Zhang N; Yin Y; Tong L; Wei Q; Liu G; Li Z; Luo J
J Biol Chem; 2020 Feb; 295(9):2760-2770. PubMed ID: 31941790
[TBL] [Abstract][Full Text] [Related]
3. A conserved docking surface on calcineurin mediates interaction with substrates and immunosuppressants.
Rodríguez A; Roy J; Martínez-Martínez S; López-Maderuelo MD; Niño-Moreno P; Ortí L; Pantoja-Uceda D; Pineda-Lucena A; Cyert MS; Redondo JM
Mol Cell; 2009 Mar; 33(5):616-26. PubMed ID: 19285944
[TBL] [Abstract][Full Text] [Related]
4. Blockade of NFAT activation by the second calcineurin binding site.
Martínez-Martínez S; Rodríguez A; López-Maderuelo MD; Ortega-Pérez I; Vázquez J; Redondo JM
J Biol Chem; 2006 Mar; 281(10):6227-35. PubMed ID: 16407284
[TBL] [Abstract][Full Text] [Related]
5. The LxVP and PxIxIT NFAT motifs bind jointly to overlapping epitopes on calcineurin's catalytic domain distant to the regulatory domain.
Gal M; Li S; Luna RE; Takeuchi K; Wagner G
Structure; 2014 Jul; 22(7):1016-27. PubMed ID: 24954618
[TBL] [Abstract][Full Text] [Related]
6. Peptides derived from transcription factor EB bind to calcineurin at a similar region as the NFAT-type motif.
Song R; Li J; Zhang J; Wang L; Tong L; Wang P; Yang H; Wei Q; Cai H; Luo J
Biochimie; 2017 Nov; 142():158-167. PubMed ID: 28890387
[TBL] [Abstract][Full Text] [Related]
7. Identification of small-molecule inhibitors of calcineurin-NFATc signaling that mimic the PxIxIT motif of calcineurin binding partners.
Matsoukas MT; Aranguren-Ibáñez Á; Lozano T; Nunes V; Lasarte JJ; Pardo L; Pérez-Riba M
Sci Signal; 2015 Jun; 8(382):ra63. PubMed ID: 26106221
[TBL] [Abstract][Full Text] [Related]
8. RCAN3, a novel calcineurin inhibitor that down-regulates NFAT-dependent cytokine gene expression.
Mulero MC; Aubareda A; Schlüter A; Pérez-Riba M
Biochim Biophys Acta; 2007 Mar; 1773(3):330-41. PubMed ID: 17270291
[TBL] [Abstract][Full Text] [Related]
9. Chemical genetics to identify NFAT inhibitors: potential of targeting calcium mobilization in immunosuppression.
Venkatesh N; Feng Y; DeDecker B; Yacono P; Golan D; Mitchison T; McKeon F
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):8969-74. PubMed ID: 15184684
[TBL] [Abstract][Full Text] [Related]
10. Interaction of calcineurin with substrates and targeting proteins.
Li H; Rao A; Hogan PG
Trends Cell Biol; 2011 Feb; 21(2):91-103. PubMed ID: 21115349
[TBL] [Abstract][Full Text] [Related]
11. Selective modulation of nuclear factor of activated T-cell function in restenosis by a potent bipartite peptide inhibitor.
Yu H; Bot I; Sliedregt K; Xu X; Bot M; van Heiningen SH; van der Marel GA; Bennett MR; Overkleeft H; van Berkel TJ; Biessen EA
Circ Res; 2012 Jan; 110(2):200-10. PubMed ID: 22116820
[TBL] [Abstract][Full Text] [Related]
12. A polypeptide inhibitor of calcineurin blocks the calcineurin-NFAT signalling pathway
Wang P; Li W; Yang Y; Cheng N; Zhang Y; Zhang N; Yin Y; Tong L; Li Z; Luo J
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):202-210. PubMed ID: 34894973
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporin a inhibits calcineurin/nuclear factor of activated T-cells signaling and induces apoptosis in retinoblastoma cells.
Eckstein LA; Van Quill KR; Bui SK; Uusitalo MS; O'Brien JM
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):782-90. PubMed ID: 15728531
[TBL] [Abstract][Full Text] [Related]
14. Enzymatic and thermodynamic analysis of calcineurin inhibition by RCAN1.
Ma Y; Jiang G; Wang Q; Sun Y; Zhao Y; Tong L; Luo J
Int J Biol Macromol; 2015 Jan; 72():254-60. PubMed ID: 25193101
[TBL] [Abstract][Full Text] [Related]
15. The PxIxIT motif of the RCAN3 inhibits angiogenesis and tumor progression in Triple Negative breast cancer in immunocompetent mice.
Biçer A; López-Henares P; Molero-Magariño M; Feu-Llauradó A; Sabariego-Navarro M; Bayod S; Padilla L; Taco MR; Larriba S; Pérez-Riba M; Serrano-Candelas E
Carcinogenesis; 2022 Sep; 43(8):808-812. PubMed ID: 35640493
[TBL] [Abstract][Full Text] [Related]
16. Structure of the calcineurin-NFAT complex: defining a T cell activation switch using solution NMR and crystal coordinates.
Takeuchi K; Roehrl MH; Sun ZY; Wagner G
Structure; 2007 May; 15(5):587-97. PubMed ID: 17502104
[TBL] [Abstract][Full Text] [Related]
17. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A.
Aramburu J; Yaffe MB; López-Rodríguez C; Cantley LC; Hogan PG; Rao A
Science; 1999 Sep; 285(5436):2129-33. PubMed ID: 10497131
[TBL] [Abstract][Full Text] [Related]
18. A proposed molecular model for the interaction of calcineurin with the cyclosporin A-cyclophilin A complex.
Ivery MT
Bioorg Med Chem; 1999 Jul; 7(7):1389-402. PubMed ID: 10465413
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of calcineurin by quercetin in vitro and in Jurkat cells.
Wang H; Zhou CL; Lei H; Wei Q
J Biochem; 2010 Feb; 147(2):185-90. PubMed ID: 19880376
[TBL] [Abstract][Full Text] [Related]
20. Modulation of calcineurin activity in mouse brain by chronic oral administration of cyclosporine A.
Liu H; Tu L; Wang Q; Sun Y; Ma Y; Cen J; Wei Q; Luo J
IUBMB Life; 2013 May; 65(5):445-53. PubMed ID: 23436429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
